Form 8-K - Current report:
SEC Accession No. 0001013762-24-001604
Filing Date
2024-07-26
Accepted
2024-07-26 16:15:20
Documents
16
Period of Report
2024-07-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea021010701-8k_60degrees.htm   iXBRL 8-K 30168
2 PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF JULY 25, 2024. ea021010701ex99-1_60degrees.htm EX-99.1 14698
7 GRAPHIC image_001.jpg GRAPHIC 6461
  Complete submission text file 0001013762-24-001604.txt   279549

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sxtp-20240725.xsd EX-101.SCH 3776
4 XBRL DEFINITION FILE sxtp-20240725_def.xml EX-101.DEF 26630
5 XBRL LABEL FILE sxtp-20240725_lab.xml EX-101.LAB 36712
6 XBRL PRESENTATION FILE sxtp-20240725_pre.xml EX-101.PRE 25254
19 EXTRACTED XBRL INSTANCE DOCUMENT ea021010701-8k_60degrees_htm.xml XML 5853
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 241147076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)